The new fight over abortion pills

When boomers die, they’ll leave trillions to their adult children. Some of those kids say they should get that money now. This episode was produced by Danielle Hewitt, edited by Jenny Lawton, fact-checked by Gabriel Dunatov, engineered by Patrick Boyd and David Tatasciore, and ho ...  Show more

The US is intentionally losing a fight against HIV that could be won. This episode was produced by Kelli Wessinger, edited by Jolie Myers and Miranda Kennedy, fact-checked by Gabriel Dunatov, engineered by Patrick Boyd and David Tatasciore, and hosted by Sean Rameswaram. Activist ...  Show more

In 2000, the F.D.A. approved the medication abortion drug mifepristone. Now a federal judge in Texas is set to rule on a case filed by anti-abortion groups urging the agency to revoke its approval of mifepristone and the other main drug used for medication abortion in the Unit ...

Today on Post Reports, we take you to an abortion hearing in Amarillo, Tex., that the judge didn’t want you to know was coming. 

Read more:

In a four-hour hearing on Wednesday, U.S. District Judge Matthew Kacsmaryk heard arguments in

A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications. Read the story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices 

Abortion pills — a combo of two drugs, mifepristone and misoprostol — are on notice: on April 7, 2023, a federal judge said the FDA’s approval of mifepristone was invalid. And then, not more than an hour later, another federal judge in a separate case said that mifepristone ha ...